Top

Published in:

01-05-2018 | Biomarkers

CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren’s syndrome

Authors: Santosh Kumar Mandal, Pulukool Sandhya, Jayakanthan Kabeerdoss, Janardana Ramya, Gowri Mahasampath, Debashish Danda

Published in: Rheumatology International | Issue 5/2018

Abstract

Human and animal model studies suggest CXCL13 is a potential biomarker in primary Sjögren’s syndrome (pSS). CXCL13 has not been studied in Indian patients with pSS. pSS cases classified by American European Consensus Group (AECG) or American college of Rheumatology(ACR) 2012 criteria, attending rheumatology clinic between July 2014 and July 2015 were included. Hospital staff and healthy, non-blood related family members of patients constituted the control group. pSS cases underwent clinical evaluation, laboratory investigations, ESSDAI and ESSPRI scoring. Unstimulated saliva was collected by the spitting method. Salivary and serum CXCL13 were quantified by indirect ELISA. CXCL13 positivity was determined using Receiver Operator Characteristic (ROC) curve. STATA13.1 (StataCorpLP,Texas,USA) software was used for statistical analysis. In this study, 45 pSS cases and 42 healthy controls were recruited. In pSS, median levels of serum CXCL13, but not salivary CXCL13 was significantly higher as compared to the corresponding levels in healthy controls (p < 0.001). Using cutoff of 43.03 pg/ml obtained by ROC, serum CXCL13 positivity was seen in 31/43(72.1%) cases and 10/34 (29.4%) controls, respectively. Serum CXCL13 levels among pSS patients on treatment, treatment naïve patients and healthy controls were statistically different. Serum CXCL13 positivity was associated with oral symptoms (p = 0.02), ocular signs (p = 0.03) and hyperglobulinemia (p = 0.01). There was no association of salivary CXCL13 level with any of the clinical variables. While serum CXCL13 was elevated in pSS, salivary CXCL13 was not. In conclusion, serum CXCL13 positivity was found to be associated with oral symptoms, ocular signs and hyperglobulinemia in pSS.

Gabriel SE, Michaud K (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 11:229. https://doi.org/10.1186/ar2669 CrossRefPubMedPubMedCentral

Vitali C, Bombardieri S, Jonsson R et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558. https://doi.org/10.1136/ard.61.6.554 CrossRefPubMedPubMedCentral

Shiboski SC, Shiboski CH, Criswell LA et al (2012) American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res 64:475–487CrossRef

Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM (2010) Characteristics of the minor salivary gland infiltrates in Sjögren’s syndrome. J Autoimmun 34:400–407. https://doi.org/10.1016/j.jaut.2009.10.004 CrossRefPubMed

Xanthou G, Polihronis M, Tzioufas AG, et al (2001) “Lymphoid” chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren’s syndrome patients: possible participation in lymphoid structure formation. Arthritis Rheum 44:408–418. https://doi.org/10.1002/1529-0131(200102)44:2<408::AID-ANR60>3.0.CO;2-0CrossRefPubMed

Barone F, Bombardieri M, Manzo A et al (2005) Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren’s syndrome. Arthritis Rheum 52:1773–1784. https://doi.org/10.1002/art.21062 CrossRefPubMed

Ansel KM, Ngo VN, Hyman PL et al (2000) A chemokine-driven positive feedback loop organizes lymphoid follicles. Nature 406:309–314. https://doi.org/10.1038/35018581 CrossRefPubMed

Luther SA, Lopez T, Bai W et al (2000) BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12:471–481CrossRefPubMed

Amft N, Curnow SJ, Scheel-Toellner D et al (2001) Ectopic expression of the B cell-attracting chemokine BCA-1 (CXCL13) on endothelial cells and within lymphoid follicles contributes to the establishment of germinal center-like structures in Sjögren’s syndrome. Arthritis Rheum 44:2633–2641CrossRefPubMed

10.

Hjelmervik TOR, Petersen K, Jonassen I et al (2005) Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren’s syndrome patients from healthy control subjects. Arthritis Rheum 52:1534–1544. https://doi.org/10.1002/art.21006 CrossRefPubMed

11.

Salomonsson S, Jonsson MV, Skarstein K et al (2003) Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren’s syndrome. Arthritis Rheum 48:3187–3201. https://doi.org/10.1002/art.11311 CrossRefPubMed

12.

Salomonsson S, Larsson P, Tengnér P et al (2002) Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sjögren’s syndrome. Scand J Immunol 55:336–342CrossRefPubMed

13.

Kramer JM, Klimatcheva E, Rothstein TL (2013) CXCL13 is elevated in Sjögren’s syndrome in mice and humans and is implicated in disease pathogenesis. J Leukoc Biol 94:1079–1089. https://doi.org/10.1189/jlb.0113036 CrossRefPubMedPubMedCentral

14.

Seror R, Gottenberg JE, Devauchelle-Pensec V et al (2013) European league against rheumatism Sjögren’s syndrome disease activity index and European League Against Rheumatism Sjögren’s syndrome patient-reported index: a complete picture of primary Sjögren’s syndrome patients. Arthritis Care Res 65:1358–1364. https://doi.org/10.1002/acr.21991 CrossRef

15.

Chisholm DM, Mason DK (1968) Labial salivary gland biopsy in Sjögren’s disease. J Clin Pathol 21:656–660. https://doi.org/10.1136/jcp.21.5.656 CrossRefPubMedPubMedCentral

16.

Jayakanthan K, Ramya J, Mandal SK et al (2016) Younger patients with primary Sjögren’s syndrome are more likely to have salivary IgG anti-muscarinic acetylcholine receptor type 3 antibodies. Clin Rheumatol 35:657–662. https://doi.org/10.1007/s10067-016-3186-0 CrossRefPubMed

17.

Kabeerdoss J, Sandhya P, Mandal SK et al (2016) High salivary soluble L-selectin and interleukin-7 levels in Asian Indian patients with primary Sjögren’s syndrome. Clin Rheumatol 35:3063–3067. https://doi.org/10.1007/s10067-016-3406-7 CrossRefPubMed

18.

Shiboski CH, Shiboski SC, Seror R et al (2016) 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome A consensus and data-driven methodology involving three international patient cohorts. Ann Rheum. https://doi.org/10.1136/annrheumdis-2016-210571 (Dis annrheumdis–2016–210571)

19.

Nocturne G, Seror R, Fogel O et al (2015) CXCL13 and CCL11 serum levels and lymphoma and disease activity in primary Sjögren’s syndrome. Arthritis Rheumatol Hoboken NJ 67:3226–3233. https://doi.org/10.1002/art.39315 CrossRef

20.

Jin L, Yu D, Li X et al (2014) CD4 + CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjogren’s syndrome. Int J Clin Exp Pathol 7:1988–1996PubMedPubMedCentral

21.

García-Carrasco M, Mendoza-Pinto C, Jiménez-Hernández C et al (2012) Serologic features of primary Sjögren’s syndrome: clinical and prognostic correlation. Int J Clin Rheumatol 7:651–659. https://doi.org/10.2217/ijr.12.64 CrossRef

22.

Nishikawa A, Suzuki K, Kassai Y et al (2016) Identification of definitive serum biomarkers associated with disease activity in primary Sjögren’s syndrome. Arthritis Res Ther 18:106. https://doi.org/10.1186/s13075-016-1006-1 CrossRefPubMedPubMedCentral

23.

Lee K-E, Kang J-H, Yim Y-R et al (2017) Predictive significance of CCL21 and CXCL13 levels in the minor salivary glands of patients with Sjögren’s syndrome. Clin Exp Rheumatol 35(2):234–240PubMed

24.

Hernández-Molina G, Michel-Peregrina M, Hernández-Ramírez DF et al (2011) Chemokine saliva levels in patients with primary Sjögren’s syndrome, associated Sjögren’s syndrome, pre-clinical Sjögren’s syndrome and systemic autoimmune diseases. Rheumatol Oxf Engl 50:1288–1292. https://doi.org/10.1093/rheumatology/ker019 CrossRef

25.

Delaleu N, Mydel P, Kwee I et al (2015) High fidelity between saliva proteomics and the biologic state of salivary glands defines biomarker signatures for primary Sjögren’s syndrome. Arthritis Rheumatol 67:1084–1095. https://doi.org/10.1002/art.39015 CrossRefPubMed

26.

Henson BS, Wong DT (2010) Collection, storage, and processing of saliva samples for downstream molecular applications. In: Oral Biology. Humana Press, Totowa, pp 21–30CrossRef

Title: CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren’s syndrome
Authors: Santosh Kumar Mandal
Pulukool Sandhya
Jayakanthan Kabeerdoss
Janardana Ramya
Gowri Mahasampath
Debashish Danda
Publication date: 01-05-2018
Publisher: Springer Berlin Heidelberg
Published in: Rheumatology International / Issue 5/2018
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-018-4006-4

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

CXCL13 levels in serum but not in saliva are elevated in Asian Indian patients with primary Sjögren’s syndrome

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2018

Ultrasound scans and dual energy CT identify tendons as preferred anatomical location of MSU crystal depositions in gouty joints

Greater rheumatoid arthritis joint improvement with more subjects achieving response across improvement categories using novel versus existing ultrasound methods

Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study

Clinical connection between rheumatoid arthritis and liver damage

2D:4D finger length ratio and radiographic hand osteoarthritis

Periodontal condition is associated with disease duration and motoric disabilities in patients with ankylosing spondylitis: results of a cross-sectional study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page